Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial

Publication date: September 2020Source: The Lancet Neurology, Volume 19, Issue 9Author(s): Peter J Goadsby, David W Dodick, Jessica Ailani, Joel M Trugman, Michelle Finnegan, Kaifeng Lu, Armin Szegedi

Source: The Lancet Neurology - August 20, 2020 Category: Neurology Source Type: research